| Application no. and date | 18701296.8 (espacenet) (Federated) (European Patent Register), 20180116 | | Patent/reg. no. and date | DK/EP 3571192, 20221130 | | Publication date | 20191127 | | Priority no. and date | US 201762447057 P, 20170117 | | EP pub. no. and date |
EP 3571192 20191127 | | Effective date | | | Applicant/owner | Astrazeneca, AB
151 85 Södertälje, SE | | Applicant ref. no. | 1613350 | | Inventor | NILSSON, Karl, Magnus, AstraZeneca
431 83 Mölndal, SE,
BERGGREN, Anna, Ingrid, Kristina, AstraZeneca
431 83 Mölndal, SE,
JOHANSSON, Johan, R., AstraZeneca
431 83 Mölndal, SE,
LEPISTÖ, Matti, Juhani, AstraZeneca
431 83 Mölndal, SE,
KETTLE, Jason, Grant, 1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA, GB,
ÅSTRAND, Annika, Birgitta, Margareta, AstraZeneca
431 83 Mölndal, SE,
KAWATKAR, Sameer, Pralhad, Astrazeneca Pharmaceuticals LP
1800 Concord Pike
Wilmington, DE 19803, US,
SU, Qibin, Astrazeneca Pharmaceuticals LP
1800 Concord Pike
Wilmington, DE 19803, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 17/14 (2006.01) , A61P 37/00 (2006.01) , C07D 403/04 (2006.01) , C07D 403/14 (2006.01) | | Title | JAK1-SELEKTIVE INHIBITORER | | Int. application no. | EP2018051038 | | Int. publication no. | WO2018134213 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
